Expected earnings - Immatics N.V.
Source: US Earnings Reports
Immatics N.V. (IMTX) is expected to report $-0.38 for Q2 2025
Immatics N.V.
NASDAQ: IMTX
IMTX Trading
-0.61% G/L:
$11.37 Last:
87,110 Volume:
$11.48 Open:
IMTX Latest News
May 30, 2026 08:00:00 am
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
May 12, 2026 07:00:00 am
Immatics Announces First Quarter 2026 Financial Results and Business Update
IMTX Stock Data
$1,341,978,928
63,814,383
N/A
32
N/A
Biotechnology & Life Sciences
Healthcare
DE
Tbingen
